18F-FDG PET in recurrent medullary thyroid carcinoma.

被引：0
|
作者：
Bruno, A [1 ]
Castellani, M [1 ]
Verga, U [1 ]
Schiavini, M [1 ]
Leo, R [1 ]
Gerundini, P [1 ]
机构：
[1] Osped Maggiore, IRCCS, Milan, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2001年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1337
引用
收藏
页码：322P / 322P
页数：1
相关论文
共 50 条
  • [31] 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma
    Bogsrud, Trond Velde
    Karantanis, Dimitrios
    Nathan, Mark A.
    Mullan, Brian P.
    Wiseman, Gregory A.
    Kasperbauer, Jan L.
    Reading, Carl C.
    Hay, Ian D.
    Lowe, Val J.
    THYROID, 2008, 18 (07) : 713 - 719
  • [32] THE ROLE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18F-FDG PET) IN PEDIATRIC MEDULLARY THYROID CARCINOMA (MTC)
    Bradford, Diana
    Akshintala, Srivandana
    Chen, Clara
    Jung, Seungyeon
    Jones, Elizabeth
    Dombi, Eva
    Whatley, Millie
    Glod, John
    Whitcomb, Trish
    Widemann, Brigitte
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 103 - 103
  • [33] The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
    Mohsen Beheshti
    Sigrid Pöcher
    Reza Vali
    Peter Waldenberger
    Gabriele Broinger
    Michael Nader
    Susanne Kohlfürst
    Christian Pirich
    Henning Dralle
    Werner Langsteger
    European Radiology, 2009, 19 : 1425 - 1434
  • [34] Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff
    Ana Reyes Romero-Lluch
    Juan Ignacio Cuenca-Cuenca
    Raquel Guerrero-Vázquez
    Antonio Jesús Martínez-Ortega
    Juan Luis Tirado-Hospital
    Isabel Borrego-Dorado
    Elena Navarro-González
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2004 - 2013
  • [35] Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff
    Reyes Romero-Lluch, Ana
    Ignacio Cuenca-Cuenca, Juan
    Guerrero-Vazquez, Raquel
    Jesus Martinez-Ortega, Antonio
    Luis Tirado-Hospital, Juan
    Borrego-Dorado, Isabel
    Navarro-Gonzalez, Elena
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 2004 - 2013
  • [36] Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
    Ong, Sena C.
    Schoder, Heiko
    Patel, Snehal G.
    Tabangay-Lim, Ida M.
    Doddamane, Indukala
    Gonen, Mithat
    Shaha, Ashok R.
    Tuttle, R. Michael
    Shah, Jatin P.
    Larson, Steven M.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 501 - 507
  • [37] Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by 18F-FDG PET/CT?
    Erdogan, Murat Faik
    Demir, Ozgur
    Ozkan, Elgin
    Kucuk, Ozlem Nuriye
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2012, 15 (02): : 155 - 156
  • [38] The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
    Beheshti, Mohsen
    Poecher, Sigrid
    Vali, Reza
    Waldenberger, Peter
    Broinger, Gabriele
    Nader, Michael
    Kohlfuerst, Susanne
    Pirich, Christian
    Dralle, Henning
    Langsteger, Werner
    EUROPEAN RADIOLOGY, 2009, 19 (06) : 1425 - 1434
  • [39] Comparison of 18F-DOPA, 68Ga-Somatostatin Analogues and 18F-FDG PET-CT in Patients with Recurrent Medullary Thyroid Carcinoma
    Treglia, G.
    Castaldi, P.
    Villani, M. F.
    Filice, A.
    Ambrosini, V
    Cremonini, N.
    Salvo, D.
    Fanti, S.
    Rufini, V
    NEUROENDOCRINOLOGY, 2011, 94 : 48 - 48
  • [40] The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma
    Goshen, E
    Cohen, O
    Rotenberg, G
    Oksman, Y
    Karasik, A
    Zwas, ST
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (09) : 959 - 961
12345